Hints and tips:
Related Special Reports
...Rahul Titus, global head of influence at Ogilvy PR, said health influence was the “new frontier” in marketing....
...Gallup, in particular, has found itself a target of authorities’ ire because its global polling has shown unfavourable attitudes towards China....
...The New York-based pharma group has acquired four companies — Arena, ReViral, Biohaven and Global Blood Therapeutics — that it expects will contribute about $10bn in revenues in 2030....
...Additional reporting by Edward White in Seoul, Joe Leahy and Sun Yu in Shanghai and Primrose Riordan in Hong Kong...
...Such a scheme would make investment in US hydrogen more attractive, they say, enabling companies to effectively store up green power generated at times of surplus — for example when the midday sun passes...
...Goldman Sachs chief executive David Solomon, speaking at the Financial Times’ Global Banking Summit in November, said that his bank was reducing its activities in the country because of growing tensions...
...Pfizer and BioNTech will dispute Moderna’s ability to withdraw the pledge when it did, given the World Health Organization did not declare the end of the “global health emergency” until March 2023....
...The FT’s global head of audio is Cheryl Brumley. The show’s theme song is by Metaphor Music. Read a transcript of this episode on FT.com...
...A version of this article was first published by Nikkei Asia on April 4 2024. ©2024 Nikkei Inc. All rights reserved....
...Lower liquidity is a factor in the UK market’s broader valuation discount to global markets — a shortfall that is now at its largest since the early 1990s....
...system, we will continue to find new and novel ways to target these diseases, and potentially, not only create a really meaningful benefit for individual patients, but also remove a lot of burden off of global...
...The first three sources are not the exclusive realm of knowledge industries such as tech or pharma....
...The global environmental protection organisation lists the American horseshoe crab as “vulnerable”....
‘We were told not to bring any Apple products’: US tech group loses $200bn in share value this week
...In 2022 the country spent more than $600bn on medicines, almost half the total global outlay, according to Statista....
...Molnupiravir’s original UK approval in November 2021 was a global first....
...Global companies are accelerating their push to decouple China data in response to the country’s increasingly stringent data and anti-espionage laws, as relations between Washington and Beijing deteriorate...
...“We are trying to build a global brand. We won’t deny our Chinese roots....
...is huge and there will be companies that will need to consider an exit from China due to concerns about their employee safety,” said Kenji Minemura, a senior research fellow at the Canon Institute for Global...
...Merck called for the UK government to do more to support the pharma industry as it opened a £1bn research centre in London....
...The bankruptcy court acknowledged this process was slow and perhaps more inefficient than a single global deal struck in bankruptcy....
...Both the tech and pharma industries are now structured in this way: small and innovative start-ups build new products in the hope of being bought by large platforms....
...Humira, the world’s best-selling drug, which has amassed $200bn in global sales for AbbVie, faced competition in Europe in 2018....
...Pfizer’s chief executive Albert Bourla said the pharma group was “deploying its financial resources to advance the battle against cancer”....
International Edition